October 23, 2025
1 min read

Lonza’s recently purchased Calif. biologics site plays key role in sales rebound

The company expects sales in the second half of the year to outpace those from the first and reiterated its annual revenue guidance, projecting growth between 20% and 21% for all of 2025.

Leave a Reply

Your email address will not be published.

Previous Story

Natalie Christensen: Committed to excellence in student and athlete nutrition at ISU

Next Story

Integrating Nutrition and Lifestyle Strategies in Pediatric Multiple Sclerosis Management | NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Previous Story

Natalie Christensen: Committed to excellence in student and athlete nutrition at ISU

Next Story

Integrating Nutrition and Lifestyle Strategies in Pediatric Multiple Sclerosis Management | NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop